The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University
The First Affiliated Hospital of Dalian Medical University
Wellmarker Bio
R-Pharm
AO GENERIUM
Lebanese University
Avistone Biotechnology Co., Ltd.
Fox Chase Cancer Center
Guangzhou Institute of Respiratory Disease
Qianfoshan Hospital
Provectus Pharmaceuticals
Wellmarker Bio
Revolution Medicines, Inc.
Imperial College London
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Massachusetts General Hospital
Shanghai Junshi Bioscience Co., Ltd.
Assiut University
Shenzhen People's Hospital
Critical Outcome Technologies Inc.
Guangzhou Institute of Respiratory Disease
Biocad
Shanghai Chest Hospital
Southwest Hospital, China
Shenzhen Second People's Hospital
Lady Davis Institute
Alliancells-PuRui Biocience Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Poniard Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Copharos